Pancreatic Cancer Research

ResearcherOregon Health & Science UniversityActive in the last 2 years

Katie E. Blise

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6433-9455; OpenAlex author ID A5076131267. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2024: 1 paper · 2025: 3 papers · 2026: 3 papers

Papers 7

  1. IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma. Co-author DOI 10.1158/2326-6066.cir-25-1612↗
  2. The Posttranscriptional Regulator HuR Promotes Immune Evasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1136/jitc-2025-sitc2025.1250↗
  3. Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies. Co-author DOI 10.1158/2767-9764.crc-25-0338↗
  4. Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2025.02.07.632847↗
  5. Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model Co-author DOI 10.1101/2025.07.14.664767↗
  6. A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway Co-author DOI 10.64898/2025.12.12.693851↗
  7. Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-23-0873↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lisa M. Coussens · 7 shared papers, 2024–2026 · strength 1.40
  2. Rosalie C. Sears · 6 shared papers, 2025–2026 · strength 1.21
  3. Jonathan Robert Brody · 5 shared papers, 2025–2026 · strength 0.98
  4. Robert L Eil · 3 shared papers, 2025–2026 · strength 0.66
  5. Zheng Xia · 3 shared papers, 2025–2026 · strength 0.65
  6. Canping Chen · 3 shared papers, 2025–2026 · strength 0.65
  7. Charles D. Lopez · 3 shared papers, 2025–2026 · strength 0.61
  8. Kevin Hawthorne · 3 shared papers, 2025–2026 · strength 0.60
  9. Aaron J. Grossberg · 2 shared papers, 2025–2026 · strength 0.43
  10. Jennifer M. Finan · 2 shared papers, 2025–2026 · strength 0.43
  11. Yifei Guo · 2 shared papers, 2025–2026 · strength 0.43
  12. Grace A. McCarthy · 2 shared papers, 2025–2026 · strength 0.43
  13. Katelyn T. Byrne · 2 shared papers, 2024–2026 · strength 0.41
  14. Katherine R. Pelz · 2 shared papers, 2025–2026 · strength 0.39
  15. Gordon Brent Mills · 2 shared papers, 2025–2026 · strength 0.38
  16. Vidhi M. Shah · 2 shared papers, 2025–2026 · strength 0.37
  17. Patrick Joseph Worth · 2 shared papers, 2025 · strength 0.33
  18. Isabel A. English · 2 shared papers, 2025 · strength 0.33
  19. Motoyuki Tsuda · 2 shared papers, 2025 · strength 0.33
  20. Jonathan J. Hue · 1 shared paper, 2026 · strength 0.23
  21. Erryk Katayama · 1 shared paper, 2026 · strength 0.23
  22. Ali Vaziri Gohar · 1 shared paper, 2026 · strength 0.23
  23. Sami O. Abul-Khoudoud · 1 shared paper, 2026 · strength 0.23
  24. Mehrdad Zarei · 1 shared paper, 2026 · strength 0.23
  25. Omid Hajihassani · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.